WMS Partners’s ResMed RMD Stock Holding History

WMS Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-10,950	Closed	-$494K	–	221
2013 Q2	$494K	Buy	+10,950	New	+$520K	0.09%	114

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

LCG

Luxor Capital Group New York $1.43B AUM 30.88% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

WMS Partners's RMD Position: Q3 2013 in Review

WMS Partners sold out of ResMed (RMD) in Q3 2013, closing a stake of 10,950 shares — an estimated $494K sold.

WMS Partners first reported a position in RMD in Q2 2013 and held it in 1 quarter. The position peaked at $494K in Q2 2013. 322 funds tracked by Wall St. Rank hold RMD as of Q3 2013.

WMS Partners reported no remaining ResMed position as of Q3 2013 after selling out during the quarter.
WMS Partners sold 10,950 ResMed shares in Q3 2013, an estimated $494K.
WMS Partners first reported a position in ResMed in Q2 2013 and held it in 1 quarter.
WMS Partners's ResMed position peaked at $494K in Q2 2013.
322 funds tracked by Wall St. Rank held ResMed as of Q3 2013.

Based on WMS Partners's 13F filing for Q3 2013, filed 15 Oct 2013.